Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Sees Significant Decline in Short Interest

Cryo-Cell International, Inc. (NYSEAMERICAN:CCELGet Free Report) saw a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 12,100 shares, a decrease of 11.0% from the December 31st total of 13,600 shares. Based on an average daily trading volume, of 10,000 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.3% of the shares of the company are short sold.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Cryo-Cell International stock. Cerity Partners LLC bought a new position in Cryo-Cell International, Inc. (NYSEAMERICAN:CCELFree Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 19,563 shares of the company’s stock, valued at approximately $83,000. Cerity Partners LLC owned about 0.23% of Cryo-Cell International as of its most recent SEC filing. 10.01% of the stock is currently owned by hedge funds and other institutional investors.

Cryo-Cell International Trading Down 3.2 %

Cryo-Cell International stock opened at $5.13 on Wednesday. Cryo-Cell International has a 12 month low of $2.69 and a 12 month high of $7.25. The stock has a 50 day moving average of $5.69. The stock has a market cap of $42.53 million, a price-to-earnings ratio of 17.67 and a beta of 0.39.

Cryo-Cell International Company Profile

(Get Free Report)

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases.

Recommended Stories

Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with's FREE daily email newsletter.